Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL

Listen to experts answer questions from a live CCO webinar on best practices in the use of approved BTK inhibitors for treating patients with CLL and MCL and potential uses of emerging investigational BTK inhibitors for these malignancies.